Glaxosmithkline Plc Adr Stock Widgets and Gadgets
GSK Stock | USD 43.47 0.03 0.07% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- GSK GlaxoSmithKline PLC ADR
- Latest Senator slams drugmaker for seeming to skirt pledge to cap inhaler cost
- GSK 43.47 -0.03
- Low 43.27
- High 43.68
- Alpha 0.11
- Beta 0.69
- Return On Equity 0.39
- Return On Asset 0.1
- Profit Margin 0.15 %
- Operating Margin 0.38 %
- Current Valuation 190.46 B
- Shares Outstanding 2.04 B
- Shares Owned By Institutions 14.86 %
- Number Of Shares Shorted 7.35 M
- Price To Earning 11.80 X
- Price To Book 4.96 X
- Price To Sales 2.75 X
- Revenue 30.33 B
- Gross Profit 19.92 B
- EBITDA 9.29 B
- Net Income 4.93 B
- Cash And Equivalents 3.72 B
- Cash Per Share 0.32 X
- Total Debt 18.02 B
- Debt To Equity 0.98 %
- Current Ratio 1.43 X
- Book Value Per Share 3.39 X
- Cash Flow From Operations 6.35 B
- Short Ratio 2.57 X
- Earnings Per Share 2.73 X
- Price To Earnings To Growth 1.09 X
- Target Price 45.59
- Number Of Employees 70.21 K
- Beta 0.27
- Market Capitalization 88.7 B
- Total Asset 59.01 B
- Retained Earnings 7.24 B
- Working Capital (2.42 B)
- Current Asset 16.59 B
- Current Liabilities 13.42 B
- Annual Yield 0.03 %
- Five Year Return 5.32 %
- Net Asset 59.01 B
- Last Dividend Paid 0.59
- Accumulation Distribution 0.0094
- Daily Balance Of Power (0.07)
- Rate Of Daily Change 1.0
- Day Median Price 43.48
- Day Typical Price 43.47
- Market Facilitation Index 0.41
- Price Action Indicator (0.02)
- Period Momentum Indicator (0.03)
Market Snapshot Widget Example
DAX Index Germany | 18,002 0.59 | |
Taiwan Weighted Taiwan | 20,330 0.53 | |
PSI 20 Stock Portugal | 6,649 0.25 | |
CROBEX Croatia | 2,814 0.05 | |
Budapest SE Hungary | 68,002 0.18 | |
IDX 30 Jakarta Indonesia | 457.92 0.50 | |
ISEQ 20 Price Ireland | 1,678 0.13 | |
NYSE Comp USA | 17,798 0.56 | |
Tel Aviv 35 Israel | 1,939 0.46 | |
Coreshares Index Tracker South Afric | 1,056 0.96 | |
IPC MEXICO Mexico | 57,135 0.81 | |
KL Technology Malaysia | 65.57 1.24 | |
IBEX 35 Index Spain | 10,855 0.16 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,591 0.02 | |
SPASX Dividend Opportunities Australia | 1,645 0.67 | |
HNX 30 Vietnam | 490.71 0.51 | |
Bucharest BET-NG Romania | 1,231 0.64 | |
AMS Small Cap Netherlands | 1,172 0.64 | |
Oslo Exchange Mutual Norway | 1,323 0.57 | |
BEL Small Belgium | 9,061 0.52 | |
RTSI Index Russia | 1,185 0.66 | |
Basic Materials Brazil | 5,890 1.82 | |
Swiss Leader Price Switzerland | 1,848 0.83 | |
Fondo Mutuo ETF Chile | 1,436 0.71 | |
Athens General Comp Greece | 1,452 0.35 | |
Stock Exchange Of Thailand | 1,370 0.49 | |
PX Prague Stock Czech Repub | 1,555 0.43 | |
THE PHILIPPINE STOCK Philippines | 6,616 0.47 | |
WIG 30 Poland | 3,063 0.58 | |
BIST Electricity Turkey | 610.92 0.19 |
Investing Ideas
In addition to having GlaxoSmithKline PLC in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare GlaxoSmithKline PLC
Compare GlaxoSmithKline PLC To Peers
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlaxoSmithKline PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for GlaxoSmithKline Stock analysis
When running GlaxoSmithKline PLC's price analysis, check to measure GlaxoSmithKline PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline PLC is operating at the current time. Most of GlaxoSmithKline PLC's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline PLC's price. Additionally, you may evaluate how the addition of GlaxoSmithKline PLC to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
Is GlaxoSmithKline PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlaxoSmithKline PLC. If investors know GlaxoSmithKline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlaxoSmithKline PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Dividend Share 0.59 | Earnings Share 2.73 | Revenue Per Share 15.15 | Quarterly Revenue Growth 0.059 |
The market value of GlaxoSmithKline PLC ADR is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlaxoSmithKline PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.